Treatment for Herpes Sexually Transmitted Disease
The recommended first-line treatment for genital herpes is valacyclovir 1000 mg three times daily for initial episodes, or 500 mg twice daily for recurrent episodes, with suppressive therapy of 500-1000 mg once daily for frequent recurrences. 1
Antiviral Treatment Options
Initial Episode of Genital Herpes
- First-line treatment options:
Recurrent Episodes of Genital Herpes
- Treatment options:
Suppressive Therapy
- For patients with frequent recurrences (≥6 episodes per year):
- Suppressive therapy reduces:
Special Considerations
Pregnant Women
- Acyclovir is the first-line treatment during pregnancy due to its established safety profile 2
- Dosage: 800 mg orally 5 times daily 2
- Treatment should be initiated within 72 hours of symptom onset 2
- Acyclovir has not been associated with increased risk of major birth defects 2, 7
Immunocompromised Patients
- May require higher doses and longer treatment duration 2
- For HIV-infected patients with CD4+ counts <200 cells/μL, higher oral doses are recommended 2
- Close monitoring for treatment response is essential 2
Severe Cases
- Intravenous acyclovir 10 mg/kg every 8 hours may be required 2
- For acyclovir-resistant infections, foscarnet 40 mg/kg IV 3 times daily is recommended 2
Treatment Timing and Follow-up
- Antiviral therapy should be initiated as soon as possible after symptom onset:
- Early treatment significantly reduces:
- Duration of viral shedding
- Time to lesion healing
- Severity of symptoms 8
- Follow-up within 7 days is recommended to assess:
- Treatment response
- Complete resolution of lesions
- Signs of complications 2
Pain Management
- For mild pain: acetaminophen or NSAIDs 2
- For moderate to severe pain: consider gabapentin, pregabalin, or tricyclic antidepressants 2
- Topical options for localized pain: lidocaine patches or 2% viscous lidocaine 2
Prevention and Patient Education
- Safer sex practices should be used even with suppressive therapy 1
- Patients should be counseled about:
The once-daily dosing regimen of valacyclovir for suppressive therapy offers a convenient option that may improve patient adherence compared to multiple daily doses required with acyclovir 4, 6.